Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-26

Clinical Trial Update: A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Alefacept in chronic plaque psoriasis patients who failed or were unsuitable for conventional therapy has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alefacept (Alefacept)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED